Skip to main content

D30.1 vs Z85.520

D30.1 (Benign neoplasm of renal pelvis) compared with Z85.520 (Personal history of malignant carcinoid tumor of kidney), from the official CMS tabular data. Z85.520 is the personal-history/screening code for the active disease D30.1 names.

Relationship

Review

Condition lifecycle relationship

Z85.520
Personal history of malignant carcinoid tumor of kidney
D30.1
Benign neoplasm of renal pelvis

Personal-history or screening code versus the active disease.

Benign neoplasm of this site (kidney)

A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code for the same site.

Source: CMS Table of Neoplasms (site match derived from the code title)

Can these codes be reported together?

History or screening versus active disease. Z85.520 is the personal-history or screening code for the active disease D30.1 names.

Site match derived from the code’s own title against the CMS Table of Neoplasms. A personal-history code describes a condition that no longer exists and is no longer being treated, so it is not interchangeable with the active-disease code.

Side by side

D30.1Benign neoplasm of renal pelvisZ85.520Personal history of malignant carcinoid tumor of kidney
Billing statusNon-billable header

Report instead: D30.10, D30.11, D30.12

Billable
ClassificationC00-D49 — Neoplasms (C00-D49)Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)
DefinitionBenign neoplasm of renal pelvis is a non-billable ICD-10-CM category code (D30.1).Personal history of malignant carcinoid tumor of kidney is a billable ICD-10-CM diagnosis code (Z85.520).
Includes
Conditions classifiable to C7A.093
Use additional code
code to identify:
alcohol use and dependence (F10.-)
exposure to environmental tobacco smoke (Z77.22)
Code first
any follow-up examination after treatment of malignant neoplasm (Z08)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources